Natick

Pillar Biosciences Inc. of Natick announced Thursday a partnership with North Carolina-based Labcorp to provide genomic testing for people with cancer.

Natick cancer treatment company Affylmmune Therapeutics, Inc. announced Thursday it has closed a $30-million Series A+ funding by ORI Capital Limited to advance a cancer treatment study.

Data software company B&L Associates Inc. purchased a 12,000-square-foot office space in Sudbury for $1.7 million in August and will move its Natick headquarters to the new location.

Pillar Biosciences in Natick announced on Wednesday the appointment of Randy Pritchard as CEO, as the company’s founder and previous CEO Dr. Gang Song will transition to the role of chairman of the board, according to a press release.

HebeCell Corp., a Natick research company focused on therapies for cancer and autoimmune disease, announced on Tuesday it has closed a $53-million Series A financing for an off-the-shelf stem cell product.

The Massachusetts Cannabis Control Commission on Thursday took issue with two provisional license applications for prospective businesses looking to open in Natick and Gardner for using identical language in their diversity plans.

Natick biotech firm Pillar Biosciences received premarket approval from the U.S. Food and Drug Administration for its oncoRevea Dx Lung and Colon Cancer Assay, according to a press release Thursday.

Online ratings firm RAVE Reviews selected Lookout Farm Brewing in South Natick and Jack's Abby Brewing from Framingham as part of its list Top Breweries in the Northeast 2021.

Natick software company on Wednesday announced it has expanded its partnership with Somerville-based climatetech startup incubator Greentown Labs.

Natick healthcare firm Allurion Technologies has rebranded its products to integrate its weight-loss balloon that doesn't require surgery and passes naturally through the body with a weight-loss program with a digital app.